![](/img/cover-not-exists.png)
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial
M Kaufmann, E Bajetta, L.Y Dirix, L.E Fein, S.E Jones, J Cervek, C Fowst, A Polli, E Di Salle, G Massimini, G PiscitelliVolume:
36
Year:
2000
Language:
english
DOI:
10.1016/s0959-8049(00)00240-9
File:
PDF, 68 KB
english, 2000